We are live on ! Find out more
GYRE icon

Gyre Therapeutics
GYRE

34 hedge funds and large institutions have $2.63M invested in Gyre Therapeutics in 2022 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 12 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 7

1.16% less ownership

Funds ownership: 3.28% → 2.11% (-1.2%)

3% less funds holding

Funds holding: 35 → 34 (-1)

32% less capital invested

Capital invested by funds: $3.9M → $2.63M (-$1.26M)

33% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 12

Holders
34
Holders Change
-1
Holders Change %
-2.86%
% of All Funds
0.55%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
8
Reduced
12
Closed
7
Calls
$173K
Puts
–
Net Calls
+$173K
Net Calls Change
-$1.12M

Top Buyers

1
Citadel Advisors
Citadel Advisors
Florida
+$136K
2
Renaissance Technologies
Renaissance Technologies
New York
+$46.6K
3
BSW
Buckingham Strategic Wealth
Missouri
+$23.5K
4
Jane Street
Jane Street
New York
+$17K
5
TSS
Two Sigma Securities
New York
+$14.2K

Top Sellers

1
NCM
Nantahala Capital Management
Connecticut
-$1.15M
2
Millennium Management
Millennium Management
New York
-$381K
3
RC
RBF Capital
California
-$51K
4
Goldman Sachs
Goldman Sachs
New York
-$46K
5
VF
Virtu Financial
New York
-$31.5K
Name Holding Trade Value Shares
Change 		Change in
Stake
Parallax Volatility Advisers
26
Parallax Volatility Advisers
California
$9.07K +$9.36K +2,293 New
CG
27
Cutler Group
California
$2K – – –
TRCT
28
Tower Research Capital (TRC)
New York
$1K -$371 -91 -33%
ASN
29
Advisory Services Network
Georgia
$528 +$543 +133 New
BNP Paribas Financial Markets
30
BNP Paribas Financial Markets
France
$146 -$24 -6 -14%
Osaic Holdings
31
Osaic Holdings
Arizona
$113 +$118 +29 New
Wells Fargo
32
Wells Fargo
California
$95 +$4 +1 +4%
RC
33
RBF Capital
California
– -$51K -13,613 Closed
Goldman Sachs
34
Goldman Sachs
New York
– -$46K -12,179 Closed
Commonwealth Equity Services
35
Commonwealth Equity Services
Massachusetts
– -$20K -5,402 Closed
SI
36
Stephens Inc
Arkansas
– -$11K -2,870 Closed
Prudential Financial
37
Prudential Financial
New Jersey
– -$10K -2,720 Closed
Two Sigma Advisers
38
Two Sigma Advisers
New York
– -$7K -1,747 Closed
SPIA
39
Steward Partners Investment Advisory
New York
– -$1K -133 Closed
Royal Bank of Canada
40
Royal Bank of Canada
Ontario, Canada
– +$4 +1 New
1
2

GYRE Hedge Fund Activity: Q4 2022 in Review

34 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Gyre Therapeutics (GYRE) for Q4 2022, worth a combined $2.63M — down 32% from $3.9M a quarter earlier.

Fund positioning in GYRE was balanced in Q4 2022: 7 funds opened new positions, 7 closed out, 8 added to existing stakes and 12 trimmed.

The largest buyer was Citadel Advisors, adding an estimated $136K. The largest seller was Nantahala Capital Management, cutting an estimated $1.15M.

  • 34 institutional investors held Gyre Therapeutics (GYRE) as of Q4 2022, down from 35 in Q3 2022.
  • Funds reported $2.63M of Gyre Therapeutics stock for Q4 2022, down 32% quarter-over-quarter.
  • 7 funds opened new Gyre Therapeutics positions in Q4 2022 and 7 closed out, a net change of 0 holders.
  • The largest Gyre Therapeutics buyer in Q4 2022 was Citadel Advisors, an estimated $136K added.
  • The largest Gyre Therapeutics seller in Q4 2022 was Nantahala Capital Management, an estimated $1.15M sold.

Based on aggregated 13F filings for Q4 2022.